The purpose of this study is to evaluate the safety and efficacy of CNTY-101, an investigational “off-the-shelf” CD19 Chimeric Antigen Receptor (CAR) Natural Killer (NK)-cell therapy, in participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results